These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37842281)
1. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse. Swartz JA; Franceschini D; Scamperle K AIMS Public Health; 2023; 10(3):658-677. PubMed ID: 37842281 [TBL] [Abstract][Full Text] [Related]
2. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder. Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615 [TBL] [Abstract][Full Text] [Related]
3. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders. O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496 [TBL] [Abstract][Full Text] [Related]
4. Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US. Han B; Jones CM; Einstein EB; Compton WM JAMA Netw Open; 2021 Oct; 4(10):e2129409. PubMed ID: 34652446 [TBL] [Abstract][Full Text] [Related]
5. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders. O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735 [TBL] [Abstract][Full Text] [Related]
6. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015. Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355 [TBL] [Abstract][Full Text] [Related]
7. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries? Grove LR; Rao N; Domino ME Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878 [TBL] [Abstract][Full Text] [Related]
8. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. Tardelli V; Xu KY; Bisaga A; Levin FR; Fidalgo TM; Grucza RA BMJ Ment Health; 2023 Jul; 26(1):. PubMed ID: 37500184 [TBL] [Abstract][Full Text] [Related]
9. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386 [TBL] [Abstract][Full Text] [Related]
10. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162 [TBL] [Abstract][Full Text] [Related]
11. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians. Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H; JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Subramaniam GA; Stitzer MA Drug Alcohol Depend; 2009 Apr; 101(1-2):13-9. PubMed ID: 19081205 [TBL] [Abstract][Full Text] [Related]
13. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees. Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873 [TBL] [Abstract][Full Text] [Related]
14. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. Hudgins JD; Porter JJ; Monuteaux MC; Bourgeois FT PLoS Med; 2019 Nov; 16(11):e1002922. PubMed ID: 31689290 [TBL] [Abstract][Full Text] [Related]
15. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries. Friedman S; Patel K; Liu Y; Hartzell S; Keller MS Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582 [TBL] [Abstract][Full Text] [Related]
16. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States. Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362 [TBL] [Abstract][Full Text] [Related]
17. The cost of opioid use disorder-related conditions in Medicare. Mark TL; Parish WJ; Weber EM; Steinberg DG; Henretty K Drug Alcohol Depend; 2023 Mar; 244():109778. PubMed ID: 36701935 [TBL] [Abstract][Full Text] [Related]
18. Correlates of Prescription Opioid Use, Misuse, Use Disorders, and Motivations for Misuse Among US Adults. Han B; Compton WM; Blanco C; Jones CM J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30153405 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in Prescription Opioid Pain Reliever Misuse Across Age Groups: 2015-2017 National Survey on Drug Use and Health. Schuler MS; Dick AW; Stein BD J Gen Intern Med; 2020 Mar; 35(3):792-799. PubMed ID: 31792871 [TBL] [Abstract][Full Text] [Related]
20. Co-occurring substance use and mental disorders among adults with opioid use disorder. Jones CM; McCance-Katz EF Drug Alcohol Depend; 2019 Apr; 197():78-82. PubMed ID: 30784952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]